JP2020524679A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524679A5 JP2020524679A5 JP2019570108A JP2019570108A JP2020524679A5 JP 2020524679 A5 JP2020524679 A5 JP 2020524679A5 JP 2019570108 A JP2019570108 A JP 2019570108A JP 2019570108 A JP2019570108 A JP 2019570108A JP 2020524679 A5 JP2020524679 A5 JP 2020524679A5
- Authority
- JP
- Japan
- Prior art keywords
- branched chain
- disease
- compound according
- chain
- straight chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762522243P | 2017-06-20 | 2017-06-20 | |
| US62/522,243 | 2017-06-20 | ||
| PCT/IL2018/050678 WO2018235079A1 (en) | 2017-06-20 | 2018-06-20 | CANNABIDIOLIC ACID ESTER COMPOSITIONS AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020524679A JP2020524679A (ja) | 2020-08-20 |
| JP2020524679A5 true JP2020524679A5 (enExample) | 2021-07-26 |
Family
ID=62875079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019570108A Pending JP2020524679A (ja) | 2017-06-20 | 2018-06-20 | カンナビジオール酸エステル組成物およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11440870B2 (enExample) |
| EP (1) | EP3509638B1 (enExample) |
| JP (1) | JP2020524679A (enExample) |
| CN (2) | CN121534035A (enExample) |
| AU (1) | AU2018287018B2 (enExample) |
| BR (1) | BR112019026916A2 (enExample) |
| CA (1) | CA3067512A1 (enExample) |
| DK (1) | DK3509638T3 (enExample) |
| ES (1) | ES2909350T3 (enExample) |
| MX (1) | MX389847B (enExample) |
| PT (1) | PT3509638T (enExample) |
| WO (1) | WO2018235079A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US11440870B2 (en) | 2017-06-20 | 2022-09-13 | University Of Guelph | Cannabidiolic acid esters compositions and uses thereof |
| US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
| EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | CANNABIGEROL SYNTHESIS |
| US20220054380A1 (en) * | 2018-12-25 | 2022-02-24 | Epm (Ip), Inc. | Cannabidioloic acid esters for cosmetic or edible compositions |
| CN118831076A (zh) * | 2019-03-12 | 2024-10-25 | Epm (Ip)公司 | 大麻素酸酯组合物及其用途 |
| MX2022002183A (es) | 2019-08-22 | 2022-05-24 | Epm Group Inc | Composiciones de éster de ácido cannabinoide y sus usos. |
| WO2021137224A1 (en) * | 2020-01-01 | 2021-07-08 | Epm Group, Inc. | Cannabidiolic acid esters for treating muscular dystrophy |
| IL275108A (en) * | 2020-06-03 | 2022-01-01 | Epm Ip Inc | Abnormal acid cannabidiol (abn-cbd) derivatives and their uses |
| LT4243797T (lt) * | 2020-11-16 | 2026-06-10 | Orcosa Inc. | Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| US20240041904A1 (en) * | 2020-12-24 | 2024-02-08 | Buzzelet Development And Technologies Ltd. | Compositions comprising cannabinoid acid esters |
| CN117813081A (zh) * | 2021-07-13 | 2024-04-02 | Epm(Ip)公司 | 用于治疗普拉德-威利综合征的大麻二醇酸酯 |
| US20230066947A1 (en) * | 2021-08-04 | 2023-03-02 | Max Hammond | Method for the augmentation of substance abuse therapies using cannabinoid formulations |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2318468A1 (fr) | 1975-07-17 | 1977-02-11 | Jaeger | Dispositif electronique d'enregistrement et de lecture de donnees concernant differents parametres au cours d'un cycle predetermine, fonction de l'un desdits parametres |
| US5342971A (en) | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
| CA2340444A1 (en) | 1998-05-04 | 1999-11-11 | The University Of Connecticut | Cannabinoids selective for the cb2 receptor |
| IL136839A (en) | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| JP2008502690A (ja) | 2004-06-15 | 2008-01-31 | アンドリュー シァン チェン， | リン脂質組成物ならびにその調製方法および使用方法 |
| EP2578561A1 (en) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Processes for the production of cannabidiol derivatives and intermediates thereof |
| CN101384012B (zh) * | 2008-10-22 | 2012-05-23 | 华为终端有限公司 | 系统端和终端的交互媒体文档更新方法及装置 |
| DE102009019322A1 (de) | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
| GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
| ES2547354T3 (es) * | 2013-09-03 | 2015-10-05 | Symrise Ag | Mezclas de compuestos cannabinoides, su preparación y uso |
| US9701618B2 (en) * | 2014-04-16 | 2017-07-11 | Vivacell Biotechnology España S.L. | Cannabidiol quinone derivatives |
| GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| GB2531283A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiols in the treatment of degenerative skeletal muscle diseases |
| EP3061450A1 (de) | 2015-02-26 | 2016-08-31 | Symrise AG | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| CN106810426B (zh) | 2016-12-29 | 2020-05-08 | 暨明医药科技（苏州）有限公司 | 一种大麻二酚的合成方法 |
| US11440870B2 (en) | 2017-06-20 | 2022-09-13 | University Of Guelph | Cannabidiolic acid esters compositions and uses thereof |
| WO2019234728A1 (en) | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
-
2018
- 2018-06-20 US US16/343,050 patent/US11440870B2/en active Active
- 2018-06-20 CA CA3067512A patent/CA3067512A1/en active Pending
- 2018-06-20 WO PCT/IL2018/050678 patent/WO2018235079A1/en not_active Ceased
- 2018-06-20 CN CN202511437638.6A patent/CN121534035A/zh active Pending
- 2018-06-20 CN CN201880041597.0A patent/CN111032088A/zh active Pending
- 2018-06-20 BR BR112019026916-9A patent/BR112019026916A2/pt not_active Application Discontinuation
- 2018-06-20 DK DK18739958.9T patent/DK3509638T3/da active
- 2018-06-20 EP EP18739958.9A patent/EP3509638B1/en active Active
- 2018-06-20 AU AU2018287018A patent/AU2018287018B2/en active Active
- 2018-06-20 ES ES18739958T patent/ES2909350T3/es active Active
- 2018-06-20 JP JP2019570108A patent/JP2020524679A/ja active Pending
- 2018-06-20 MX MX2019015311A patent/MX389847B/es unknown
- 2018-06-20 PT PT187399589T patent/PT3509638T/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516941A5 (enExample) | ||
| JP2019532079A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| RU2014145682A (ru) | Органические соединения | |
| JOP20230235A1 (ar) | عقاقير أولية جديدة من الكاتيكولامين للاستخدام في علاج مرض باركنسون | |
| JP2018519329A5 (enExample) | ||
| JP2009542595A5 (enExample) | ||
| JP2015511958A5 (enExample) | ||
| JP2011516417A5 (enExample) | ||
| JP2013519684A5 (enExample) | ||
| JP2013526544A5 (enExample) | ||
| CA2676456A1 (en) | Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof | |
| JP2015531764A5 (enExample) | ||
| JP2013533287A5 (enExample) | ||
| JP2014501789A5 (enExample) | ||
| WO2008151841A3 (en) | Treatment for alzheimer' s disease | |
| PH12014502670A1 (en) | Prodrug of fluorine - containing amino acid | |
| TNSN07365A1 (fr) | Traitement de la maladie de parkinson, de l'apnee obstructive du sommeil, de la demence a corps de lewy, de la demence vasculaire, avec des ligands du recepteur h3 de l'histamine non-imidazole-alkylamines | |
| JP2013509441A5 (enExample) | ||
| JP2012508275A5 (enExample) | ||
| EP2328584A4 (en) | TREATMENT OF NEUROLOGICAL DISEASES WITH HUPERZIN | |
| JP2012531402A5 (enExample) | ||
| JP2021525270A5 (enExample) | ||
| EA200702020A1 (ru) | Новые соединения, их изомеры или фармацевтически приемлемые соли в качестве антагонистов ваниллоидных рецепторов и содержащие их фармацевтические композиции | |
| EP2219447A4 (en) | S-ALKYLISOTHIOURONIUM DERIVATIVES FOR THE TREATMENT OF UTERUS HYPERCONTACTILITY DISORDERS |